Home/Filings/4/0001562180-24-001986
4//SEC Filing

Weinberg Uri 4

Accession 0001562180-24-001986

CIK 0001645113other

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 4:35 PM ET

Size

12.3 KB

Accession

0001562180-24-001986

Insider Transaction Report

Form 4
Period: 2024-02-27
Weinberg Uri
Chief Innovation Officer
Transactions
  • Award

    Ordinary Shares

    2024-02-27$16.30/sh+81,799$1,333,324171,148 total
  • Award

    Stock Options (Right to buy)

    2024-02-27$16.30/sh+125,078$2,038,771125,078 total
    Exercise: $16.30From: 2025-02-27Exp: 2034-02-26Ordinary Shares (125,078 underlying)
Footnotes (2)
  • [F1]Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
  • [F2]Options to buy 125,078 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001811030

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:35 PM ET
Size
12.3 KB